Search
Menu
Home
HTB
2008
August
HTB
August 2008
Contents
Editorial
Volume 9 Number 7/8 Jul/Aug 2008
Conference reports
XVII International HIV Resistance Workshop (IHDRW), 6-10 June 2008, Sitges
Integrase inhibitor resistance and cross-resistance: weighing viral fitness and the option to benefit from second-generation compounds
Understanding etravirine susceptibility: new weighted genotype score and phenotypic cut-offs
Pipeline antiretrovirals: IDX899, CHX157 and bevirimat
Lack of virological impact of treatment intensification in suppressed patients supports latent viral reservoir as source of residual viraemia
NNRTI resistance in infants prophylaxed with single-dose nevirapine varies by the timing of infection
Detecting viral tropism: impact of a more sensitive Trofile (ES) assay
Low frequency K103N mutations are associated with poor virological response to NNRTI based therapy
14th Annual BHIVA Conference, 23-25 April 2008, Belfast
Bone problems raised in several UK studies
Late diagnosis in adolescence of vertically acquired HIV infection
Case study of multi-drug resistant woman receiving newer antiretroviral drugs in pregnancy
Predictors of treatment failure in Western Cape, South Africa
Late pregnancy loss in HIV-positive women
Renal tubular dysfunction with tenofovir-based HAART in four vertically infected adolescents
15th Conference on Retroviruses and Opportunistic Infections, Boston, 2-6 February 2008
The unmet need for contraception services for women receiving ART
Valacyclovir decreases plasma and genital viral loads in HSV-2/HIV-1 co-infected women
HPV genotypes in HIV-positive women in Zimbabwe and Uganda
Antiretrovirals
Boosted atazanavir approved in Europe as first-line therapy
BMS and Merck discontinue 100mg capsule formulation of efavirenz used for paediatric treatment
Saquinavir (Invirase) interactions with digoxin, garlic capsules, methadone, tipranavir and omeprazole: US label changes
US label changes for nevirapine paediatric solution
New US pediatric dosing for lopinavir/r
New US pediatric dosing for tipranavir/r
DSMB stops ACTG study due to suboptimal responses
Treatment access
FDA approval of generic ARVs
Access to generic efavirenz in South Africa: MSD agrees to grant licenses on reasonable terms
Reaching 3 by 5…by 7: new report on universal access
Oxfam criticises DFID’s new strategy as a “missed opportunity”
Pregnancy
Low rates of MTCT in UK and Ireland
Paediatric care
WHO recommends treating all HIV-infected infants aged less than 12 months
Plasma concentrations and virologic evaluations after stopping NNRTI treatment in PENTA 11
Guidelines
UK (BHIVA) 2008 Treatment Guidelines published online
Major updates to US guidelines on prevention and treatment of OIs (2008)
Basic science and immunology
Elite control of a virus that caused AIDS in the transmitting partner
Presentations from the May 21-23 HIV Vaccine Trials Network (HVTN) Meeting
Failure of STEP leads TAG to criticise the proposed PAVE100A vaccine trial
Other news
Free osteopathy for people with HIV at the British School of Osteopathy
AIDS denialists shut out of Senate hearing after winning “whistleblower” award
MTV internet game challenges ignorance and assumptions about who has HIV
On the web
PRN notebook
JACI special issue on prospects for eradication
New resources from HIV InSite
Overview of mucosal transmission
PDFs
Volume 9 Number 7/8 Jul/Aug 2008 PDF
HTB RSS
Early access
Bipolar disorder in people living with HIV
1 November 2024
Mpox breakthrough cases after two doses of the MVA-BN vaccine
1 November 2024
Management of drug resistance to integrase inhibitors: results from an international perinatal virtual clinic
1 November 2024
All early access reports
Current issues
November 2024
October 2024
September 2024
Back issues
Special report
HTB news: i-Base changes during 2024
1 November 2024
More from HTB
Conference reports
Conference shortcuts
Articles by subject
PDFs
Subscribe
HTB homepage
Home
i-Base homepage
Donate